EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

Shuxin Wei, Chuangye Han, Shutian Mo, Hailian Huang, Xiaoling Luo

Apoptosis · 2025-02 · 30 (1-2) · 401-421

DOI: 10.1007/s10495-024-02038-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Apoptosis, online erschienen am 02.11.2024. Verfasst von Shuxin Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China. Hauptthemen laut MEDLINE: Neoplasms, Apoptosis, Antineoplastic Agents. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell death is a normal physiological process within cells that involves multiple pathways, such as normal DNA damage, cell cycle arrest, and programmed cell death (PCD). Cell death has been a hot spot of research in tumor-related fields, especially programmed cell death, which is a key form of cell death and is classified into different types according to the mechanism of occurrence, such as apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and disulfidptosis. Given the important role of PCD in maintaining tissue homeostasis and inhibiting tumorigenesis and development, more and more basic and clinical studies are devoted to revealing its potential application in anti-tumor strategies. The purpose of this review is to systematically review the regulatory mechanisms of PCD and to summarize the latest research progress of anti-tumor treatment strategies based on PCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsApoptosisAntineoplastic AgentsHumansAutophagyAnimalsFerroptosisNecroptosisPyroptosis

Stichwörter der Autor:innen

Cell deathProgrammed cell deathTargeted therapyTumor

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China.
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, 530021, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
  • School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, China. luoxiaoling67@126.com.
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, 530021, China. luoxiaoling67@126.com.
  • Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, 530021, China. luoxiaoling67@126.com.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Wei, S., Han, C., Mo, S., Huang, H., & Luo, X. (2025). Advancements in programmed cell death research in antitumor therapy: a comprehensive overview. Apoptosis, 30(1-2), 401-421. https://doi.org/10.1007/s10495-024-02038-0

Vancouver

Wei S, Han C, Mo S, Huang H, Luo X. Advancements in programmed cell death research in antitumor therapy: a comprehensive overview. Apoptosis. 2025;30(1-2):401-421. doi:10.1007/s10495-024-02038-0

BibTeX
@article{Wei2025,
  author = {Wei, Shuxin and Han, Chuangye and Mo, Shutian and Huang, Hailian and Luo, Xiaoling},
  title = {Advancements in programmed cell death research in antitumor therapy: a comprehensive overview},
  journal = {Apoptosis},
  year = {2025},
  volume = {30},
  number = {1-2},
  pages = {401--421},
  doi = {10.1007/s10495-024-02038-0}
}
Kostenlos starten →